Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up
-
Published:2020
Issue:7-8
Volume:104
Page:551-558
-
ISSN:0042-1138
-
Container-title:Urologia Internationalis
-
language:en
-
Short-container-title:Urol Int
Author:
Tamalunas AlexanderORCID, Buchner AlexanderORCID, Kretschmer Alexander, Jokisch Friedrich, Schulz Gerald, Eismann Lennert, Stief Christian G., Grimm Tobias
Reference29 articles.
1. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013 Feb;63(2):234–41. 2. Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, et al. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int. 2014 Nov;114(5):719–26. 3. Charlton ME, Adamo MP, Sun L, Deorah S. Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004-2010. Cancer. 2014 Dec;120 Suppl 23:3815–25. 4. Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 2006 Oct;176(4 Pt 1):1354–61; discussion 1361–2. 5. Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, et al. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Ann Surg Oncol. 2013 Mar;20(3):1027–34.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|